
Internal Reference Number: FOI_9171
Date Request Received: 16/01/2026 00:00:00
Date Request Replied To: 21/01/2026 00:00:00
This response was sent via: By Email
Request Summary: Spinal Muscular Atrophy (SMA)
Request Category: Researcher
| Question Number 1: I have a freedom of information request related to the diagnosis and treatment of Spinal Muscular Atrophy. Your answers to the following questions would be greatly appreciated. How many patients have a current diagnosis for Spinal Muscular Atrophy (ICD-10 Code G12.0, G12.1, G12.8 and G12.9) at your trust? | |
| Answer To Question 1: 22 patients | |
| Question Number 2: How many patients have been treated in the last 4 months (September to December 2025) with the following products: • Evrysdi (Risdiplam) - total patients • Spinraza (Nusinersen) - total patients • Zolgensma (Onasemnogene) - total patients • Evrysdi (Risdiplam) – new* patients • Spinraza (Nusinersen) – new* patients • Zolgensma (Onasemnogene) – new* patients *new patients are defined as patients who were not treated with any of Spinraza (Nusinersen), Evrysdi (Risdiplam) or Zolgensma (Onasemnogene) in the previous 4-month period (May to August 2025). | |
| Answer To Question 2: 0 patients | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.